Migraine pathophysiology;Fisiopatologia da enxaqueca

Arquivos de Neuro-Psiquiatria

Volumn 56, Issue 4, 1998, Pages 841-851

  Vincent, Maurice B ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Migraine; Pathophysiology

Indexed keywords

HUMAN; MIGRAINE; PATHOPHYSIOLOGY; REVIEW;

HUMANS; MIGRAINE DISORDERS;

EID: 0032234567     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x1998000500024     Document Type: Article

References (60)

1. Graham JG, Wolff HG. Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 1938;39:737-763.
2. Olesen J, Larsen B, Lauritzen M. Focal Hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9 344-352.
3. Leão AAP. Spreading depression of activity in cerebral cortex. J Neurophysiol 1944;7.359-390.
4. Friberg L, Olesen J, Iversen HK, Sperling B Migraine Pain associated with middle cerebral artery dilatation: reversal by sumatriptan Lancet 1991;338.13-17.
5. Vincent MB, White LR, Bakken IJ, Sjaastad O Sumatriptan relaxes isolated porcine ophthalmic artery, but inhibits VIP-induced relaxation Cephalalgia 1993;13.378-382.
6. Lundberg JM, Hokfelt T, Schultzberg M, Uvnas-Wallensten K, Köhler C, Said SI. Occurence of vasoactive intestinal polypeptide (VIP)-like immunoreactivity in certain cholinergic neurons of the cat: evidence from combined immunohistochemistry and acetylcholinesterase staining Neuroscience 1979,4:1539-1559.
7. Uddman R, Edvinsson L Neuropeptides in the cerebral circulation Cerebrovasc Brain Metab Rev 1989,1:230-252.
8. Lundberg JM. Pharmacology of cotransmission in the autonomic nervous system integrative aspects on amines, neuropeptides, adenosine triphosphate, aminoacids and nitric oxide. Pharmacol Rev 1996;48 113-178
9. Vincent MB, White LR, Elsås T, Qvigstad G, Sjaastad O. Substance P augments the rate of vasodilation induced by calcitonin gene-related peptide in porcine ophthalmic artery in vitro Neuropeptides 1992;22 137-141.
10. Le Greves P, Nyberg F, Terenius L, Hökfelt T. Calcitonin gene related peptide is a potent inhibitor of substance P degradation Eur J Pharmacol 1985,115:309-311.
11. Sakurai T, Yanagisawa M, Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci 1992,13:103-108
12. Gallai V, Sarchielli P, Firenze C, et al Endothelin-1 in migraine and tension-type headache. Acta Neurol Scand 1994,89:47-55.
13. White LR, Vincent MB, Arcanjo HMG, Araújo PLM, Stovner LJ, Aasly J. Increased plasma level of endothelin-1 in cluster headache In Olesen J, Edvinsson L (eds) Frontiers in headache research, Vol 7 Headache pathogenesis: monoamines, neuropeptides, purines, and nitric oxide. Philadelphia: Lippincott-Raven 1997:211-214
14. Goabsby PJ, Adner M, Edvinsson L. Characterization of endothelin receptors in the cerebral vasculature and their lack of effect on spreading depression. J Cer Blood Flow Metab 1996;16:698-704
15. Furchgott RF, Zawadzki JV The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288 373-376.
16. Moncada S, Palmer RMJ, Higgs EA Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991,43 109-141
17. Olesen J, Thomsen LL, Lassen LH, Olesen IJ The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 1995;15 94-100
18. Lassen LH, Ashina M, Christiansen I, et al Nitric oxide synthase inhibition, a new principle in the treatment of migraine attacks. Cephalalgia 1998; 18 27-32.
19. Limmroth V, Cutrer FM, Moskowitz MA Neurotransmitters and neuropeptides in headache. Curr Opin Neurol 1996;9:206-210.
20. Chopp M, Chen Q, Zhang ZG, Bodzin G, Welch KMA. Nitric oxide synthase is induced in cerebral endothelial cells by spreading depression (Abstract) Cephalalgia 1983;13[Suppl 13]:116.
21. Moskowitz MA The neurobiology of vascular head pain Ann Neurol 1984,16 157-168
22. Goadsby PJ, Edvinsson L, Ekman R Vasoactive peptide release in the circulation of humans during migraine headaches. Ann Neurol 1990,28:183-187.
23. Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the external circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 1988;23:193-196
24. Diener HC, for the RPR 100893/201 Migraine Study Group., Substance P antagonist RPR 100S93/201 is not effective in human migraine attacks (Abstract) Sixth International Headache Research Seminar. Copenhagen, Denmark 1995.
25. May A, Gijsman HJ, Wallofer A, Jones R, Diener HC, Ferrari MD. Endothelin antagonist bosentan blocks neurogenic inflamation, but is not effective in aborting migraine attacks. Pain 1996;67:375-378
26. Ferrari MD, Saxena PR On serotonin and migraine a clinical and pharmacological review. Cephalalgia 1993,13.151-165
27. Kimball RW, Friedman AP, Vallejo E. Effect of serotonin in migraine patients. Neurology 1960;10 107-111.
28. Hoyer D, Clarke DE, Fozard JR, et al International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin) Pharmacol Rev 1994;46 157-203
29. 1-like receptor Cephalalgia 1992,12:202-205.
30. Fennik W, Humphrey PP, Perren MJ, Connor HE, Whalley ET Rationale for the use of 5-HT1-like agonists in the treatment of migraine. J Neurol 1991,238 (Suppi 1).S57-S61
31. Buzzi MG, Moskowitz MA The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater Br J Pharmacol 1990,99:202-209
32. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 1992.13:307-311
33. Beattie DT, Connor HE The pre- and postjunctional activity of CP-122,288. a conformationally restricted analogue of sumatriptan. Eur J Pharmacol 1995,276:271-276.
34. Yu XJ, Waeber C, Castanon N, et al 5-Carboxamido-tryptamine. CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymeth yl-glycyl -tyrosinamide block durai plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine 1B receptors. Molec Pharmacol 1996;49.761-765
35. 3H]Sumatriptan-binding sites in post-mortem human brain. Cephalalgia 1996;16.317-322
36. Clifford Rose F Sumatriptan arrests migraine aura Headache 1992,32-365-366
37. Maranhão-Filho PA, Martins-Ferreira H, Vincent MB, Ribeiro LJC, Novis SAP. Sumatriptan blocks spreading depression in isolated chick retina Cephalalgia 1997;17 822-825
38. Goadsby PJ, Hoskin KJ. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5-HT)1B/D receptor agonist zolmitriptan (311C90) are brain sites therapeutic target in migraine? Pain 1996,67.355-359
39. Lashley KS. Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatry 1941;46:259-264
40. Leão AAP, Morison RS Propagation of spreading cortical depression J Neurophysiol 1945;8:33-45.
41. Moskowitz MA, Nozaki K, Kraig RP. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 1993;13.1167-1177.
42. Ingvardsen BK, Laursen H, Olsen UB, Hansen AJ. Possible mechanism of c-fos expression in trigeminal nucleus caudalis following cortical spreading depression Pain 1997;72 407-415
43. Wahl M, Schilling L, Parsons AA, Kaumann A Involvement of calcitonin gene-related peptide (CGRP) and nitric oxide (NO) in the pial artery dilatation elicited by cortical spreading depression Brain Res 1994,637:204-210
44. Piper RD, Edvinsson L, Ekman R, Lambert GA Cortical spreading depression does not result in the release of calcitonin gene-related peptide into the external jugular vein of the cat: relevance to human migraine. Cephalalgia 1993;13:180-183.
45. Mayevsky A, Doron A, Manor T, Meilin S, Zarchin N, Ouaknine GE. Cortical spreading depression recorded from the human brain using a multiparametric monitoring system Brain Res 1996,740:268-274.
46. Woods RP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994;331:1689-1692
47. Weiller C, May A, Limmroth V, et al Brain stem activation in human migraine attacks. Nature Med 1995,1.658-660.
48. Flippen C, Welch KMA Imaging the brain of migraine sufferers Curr Opin Neurol 1997,10 226-230
49. Barkley GL, Tepley N, Nagel-Leiby S, Moran JE, Simkins RT, Welch KMA. Magnetoencephalographic studies of migraine Headache 1990;30.428-434.
50. Welch KMA, Levine SR, D'Andrea G, Helpern JA. Brain pH in migraine: an in vivo phosphorus-31 magnetic resonance spectroscopy study Cephalalgia 1988;8 273-277
51. Russell MB, Olesen J. Increased familial risk and evidence of genetic factor in migraine. BMJ 1995;311:541-544.
52. Stewart WF, Staffa J, Lipton RB, Ottmann R. Familial risk of migraine, a population-based study. Ann Neurol 1997,41:166-172.
53. Honkasalo ML, Kaprio J, Winter T, Hekkila K, Sillanpaa M, Koskenvuo M. Migraine and concomitant symptoms among 817 adult twin pairs. Headache 1995,35:70-78
54. Jung HH, Bassetti C, Tournier-Lasserve E, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy a clinicopathological and genetic study in a Swiss family. J Neurol Neurosurg Psychiatry 1995;59 138-143
55. Verin M, Rolland Y, Landgraf F, et al New phenotype of the cerebral autosomal dominant arteriopathy mapped to chromosome 19 migraine as the prominent clinical feature. J Neurol Neurosurg Psychiatry 1955;59-579-585.
56. Chabriat H, Vehedi K, Iba-Zizen MT, et al Clinical spectrum of CADASIL- a study of 7 families. Lancet 1995,346:934-939
57. Terwindt GM, Haan J, Ophoff RA, Frants RR, Ferrari MD. The quest for migraine genes Curr Opin Neurol 1997;10:221-225.
58. 2+ channel gene CACNL1A4 Cell 1996,87:543-552.
59. Ducros A, Joutel A, Vahedi K, et al Mapping of a second locus for familial hemiplegic migraine to 1q21-23 and evidence of further genetic heterogeneity Ann Neurol 1997,42 885-890
60. Gardner K, Barmada MM, Ptacek LK, Hoffman EP. A new locus for hemiplegic migraine maps to chromossome 1q31. Neurology 1997,49 1231-1238